{"id":2944,"date":"2026-06-24T19:44:55","date_gmt":"2026-06-24T19:44:55","guid":{"rendered":"https:\/\/drsoniafawad.com\/?p=2944"},"modified":"2026-06-24T19:44:55","modified_gmt":"2026-06-24T19:44:55","slug":"millions-of-women-overdue-for-common-cancer-screenings","status":"publish","type":"post","link":"https:\/\/drsoniafawad.com\/?p=2944","title":{"rendered":"Millions of women overdue for common cancer screenings"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div data-component=\"ArticleContent\">\n<div class=\"article__below-title\">\n<div class=\"mobile-trust-box\">\n<div class=\"row\">\n<div class=\"col-12 col-md-5 d-xl-none\">\n<div class=\"trust-box\">\n<div class=\"trust-box-logo d-none d-md-block\">\n<img decoding=\"async\" src=\"https:\/\/www.healio.com\/~\/media\/h5\/feature\/news\/publogos\/hot.svg?la=en&amp;h=24&amp;w=141&amp;hash=2F86D471C8514C0E334E329AA799E8B4\" class=\"logo-img\" height=\"24\" alt=\"hemonc today logo\" width=\"141\"\/>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"col-12 col-md-6 offset-md-1 offset-xl-0 col-xl-12\">\n<div class=\"email-alert-button-wrapper d-none\" data-component=\"EmailTopicAlert\" data-module=\"Subspecialty Email Topic Alerts Top\" data-manage-email-link=\"\/footer\/account-information\/my-account\/email-subscriptions-and-alerts#emailAlerts\">\n<hidden data-setting-item=\"d265901d-6d37-49c7-a8f6-c7bf19a02509\"\/><br \/>\n<hidden data-crm-source=\"Subspecialty Topic Alert\"\/><\/p>\n<div class=\"email-alert-button d-none\" data-topic-button=\"not-subscribed\">\n<p>\n<span data-module-track-action=\"Email Alerts TOP_Click_Healio News Article\" data-module-track-label=\"Email Alerts TOP_Healio News Article\"><br \/>\n<i class=\"fas fa-plus-circle\"\/><br \/>\nAdd topic to email alerts<br \/>\n<\/span>\n<\/p>\n<div class=\"email-alert-inner collapse uef361e678cee455b9277cd626777d078\">\n<div class=\"email-alert-dialogue\">\n<p>\nReceive an email when new articles are posted on <span data-content=\"topic-title\"\/>\n<\/p>\n<div class=\"d-none\" data-sign-up-type=\"unknown\">\nPlease provide your email address to receive an email when new articles are posted on <span data-content=\"topic-title\"\/>.<\/p>\n<\/div>\n<\/div>\n<p><button type=\"button\" class=\"btn btn-primary\" data-loading-text=\"Loading &lt;i class=\" fa=\"\" fa-spinner=\"\" fa-spin=\"\">&#8221; data-action=subscribe&gt;<br \/>\nSubscribe<br \/>\n<\/button>\n<\/div>\n<\/div>\n<div class=\"d-none\" data-topic-modal=\"failed\"> <strong>We were unable to process your request. Please try again later. If you continue to have this issue please contact <a href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260624\/mailto:customerservice@slackinc.com\">customerservice@slackinc.com<\/a>.<\/strong> <\/p>\n<p><button data-dismiss=\"modal\" class=\"btn btn-primary btn-lg btn-block\">Back to Healio<\/button><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<h2>Key takeaways:<\/h2>\n<ul>\n<li>Researchers estimate almost 18 million women aged 45 to 64 years are not up to date with breast, cervical or colorectal cancer screenings.<\/li>\n<li>More than 3 million women may be overdue for all those screenings.<\/li>\n<\/ul>\n<p>Nearly 18 million women in the U.S. aged 45 to 64 years are likely overdue for breast, cervical or colorectal cancer screenings, and more than 3 million are estimated to not be up to date on all three.<\/p>\n<p>Survey data from 68,000 women showed that having annual wellness visits and a regular health care provider significantly increased the likelihood of being up to date with at least one, as well as all screenings. Greater educational attainment and being insured also were associated with higher screening uptake.<\/p>\n<figure class=\"figure article__og-image\">\n<picture><source srcset=\"https:\/\/www.healio.comhttps:\/\/www.healio.comhttps:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/06_june\/hot0626spencer_graphic_01.webp?w=476\" media=\"(max-width: 768px)\"><source srcset=\"https:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/06_june\/hot0626spencer_graphic_01.webp?w=800\" media=\"(max-width: 992px)\"><source srcset=\"https:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/06_june\/hot0626spencer_graphic_01.webp?w=595\" media=\"(max-width: 1200px)\"><source srcset=\"https:\/\/www.healio.comhttps:\/\/www.healio.comhttps:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/06_june\/hot0626spencer_graphic_01.webp?w=476\" media=\"(min-width: 1200px)\"><source srcset=\"https:\/\/www.healio.comhttps:\/\/www.healio.comhttps:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/06_june\/hot0626spencer_graphic_01.webp?w=476\"><img decoding=\"async\" src=\"https:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/06_june\/hot0626spencer_graphic_01.jpg?w=800\" alt=\"Number of women aged 45-64 years estimated to be overdue for breast, cervical and\/or colorectal cancer screenings IG\" class=\"figure-img img-fluid\" width=\"800\"\/><br \/>\n<\/source><\/source><\/source><\/source><\/source><\/picture><figcaption class=\"figure-caption\">\nData derived from Spencer JC, et al. <i>JAMA <\/i><i>Netw<\/i><i> Open<\/i>. 2026;doi:10.1001\/jamanetworkopen.2026.12976.<br \/>\n<\/figcaption><\/figure>\n<p>However, interventions targeting multiple screenings could be beneficial, as only 50% of the cohort reported having all their tests completed.<\/p>\n<div class=\"mug left\"><img decoding=\"async\" alt=\"Jennifer C. Spencer, PhD\" style=\" height:106px; width:80px\" src=\"https:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/mugs\/s\/spencer_jennifer_2026_.jpg\"\/><\/p>\n<p><strong><b>Jennifer C. Spencer<\/b><\/strong><\/p>\n<\/div>\n<p>\u201cWe tend to think about these [screenings] in silos,\u201d <b>Jennifer C. Spencer, PhD,<\/b> assistant professor in the departments of population health and internal medicine at The University of Texas at Austin Dell Medical School, told Healio.<\/p>\n<p>\u201cPeople tend to research one <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260527\/cookiecutter-screening-guidelines-overlook-many-patients-at-high-risk-for-cancer\" id=\"rId11\" target=\"_blank\">cancer screening<\/a> or develop interventions to address <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260615\/qa-common-pesticide-linked-to-earlyonset-colorectal-cancer\" id=\"rId12\" target=\"_blank\">colorectal cancer<\/a> screening, or breast cancer screening, or cervical cancer screening. Those are really important, but we really have a chance to intervene holistically with those folks who are due for screenings, and identify everything that they\u2019re due for.\u201d<\/p>\n<h2>\u2018Are there patterns?\u2019<\/h2>\n<p>Cancer is the leading cause of death among women aged 45 to 64 years in the U.S., according to study background.<\/p>\n<p>More than 70,000 women will die from breast, cervical or colorectal cancer alone this year, according to American Cancer Society\u2019s <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260113\/stunning-victory-70-of-people-with-cancer-survive-at-least-5-years\" id=\"rId13\" target=\"_blank\">Cancer Statistics<\/a> 2026 report.<\/p>\n<p>Prior research has shown that patients who screen for these malignancies are diagnosed at earlier stages and have improved cancer-specific mortality.<\/p>\n<p>However, many women are not up to date on screening. NCI estimates 20.2% of eligible patients have not had a mammogram in the past 2 years, and the numbers increase for those who are overdue for cervical (24.1%) and colorectal cancer (26.1%) screenings.<\/p>\n<p>\u201cWe see so many similar patterns in who doesn\u2019t get screened for <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260605\/mediterranean-diet-exercise-vitamin-d-improve-metabolic-health-in-breast-cancer\" id=\"rId14\" target=\"_blank\">breast cancer<\/a>, for cervical cancer and for colorectal cancer,\u201d Spencer said. \u201cInsurance, access to care, having a regular care provider are commonly associated with lower screening rates.\u201d<\/p>\n<p>Yet, most investigations and interventions focus solely on screening for a single malignancy, even though there can be broad eligibility overlap, particularly for patients aged 45 to 64 years.<\/p>\n<p>\u201cWhat if we looked at all of this in one question?\u201d Spencer asked. \u201cWhat are the patterns within these three cancer screenings for the women who are due? Are there patterns that are very clear about who is due for just one, or all three, or none?\u201d<\/p>\n<p>Spencer and colleagues used data from the 2024 Behavioral Risk Factor Surveillance Survey, a nationally representative survey, to investigate.<\/p>\n<p>Their final sample included 68,111 women (mean age, 54.8 years; standard deviation, 5.8; 69.6% white), which represented a weighted U.S. population of 36.2 million.<\/p>\n<p>Up to date use of breast, cervical and <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260127\/changes-to-medicaid-could-result-in-more-than-1-million-missed-cancer-screenings\" id=\"rId15\" target=\"_blank\">colorectal cancer screenings<\/a> served as the primary endpoint.<\/p>\n<h2>\u2018Halfway there\u2019<\/h2>\n<p>Researchers found 50.3% of women to be up to date with all three screenings, 28.8% with two and 13.2% with one, while 7.7% were not up to date with any screenings.<\/p>\n<p>\u201cWe were surprised at the women who were up to date on some, but not all screenings,\u201d Spencer said. \u201cI expected it to be either you\u2019re pro-screening and you get everything, or you\u2019re less likely to screen and you get nothing.\u201d<\/p>\n<p>\u201cHalf of women being up to date on all three was lower than I expected, but my clinical colleagues were pleasantly surprised that half of women were up to date,\u201d she added. \u201cThey spend so much of their time trying to get people to use these cancer screenings, they were like, \u2018We\u2019re halfway there. That\u2019s pretty good.\u2019\u201d<\/p>\n<p>Factors that had a significant association with being up to date for at least one screening compared with none included having a checkup in the previous year (adjusted RR = 1.22; 95% CI, 1.19-1.25), having a regular health care practitioner (aRR = 1.18; 95% CI, 1.13-1.23), being Black (aRR = 1.02; 95% CI, 1.01-1.04) or Hispanic (aRR = 1.06; 95% CI, 1.05-1.08) vs. white, having a high school degree or greater educational attainment, having insurance, being older, and being able to afford care in the previous year.<\/p>\n<p>Most of those factors also had a significant association with being up to date with all screenings vs. any screening, but with greater magnitudes.<\/p>\n<p>Women up to date with all their screenings had a higher likelihood of having a wellness visit in the past year (aRR = 1.71; 95% CI, 1.57-1.86), a regular health care practitioner (aRR = 1.43; 95% CI, 1.24-1.66), private insurance compared with no insurance (aRR = 1.43; 95% CI, 1.24-1.63), a college degree vs. not finishing high school (aRR = 1.28; 95% CI, 1.16-1.41), and older age (age 60-64 years vs. 45-50; aRR = 1.57; 95% CI, 1.49-1.66).<\/p>\n<p>\u201cGetting people in the door is huge, but for people who have some but not all screenings, 80% of that group did have a wellness visit in the past year,\u201d Spencer said. \u201cWe see that there\u2019s room for improvement.\u201d<\/p>\n<p>Women living in rural areas had significantly lower odds of having all screenings completed (aRR = 0.94; 95% CI, 0.89-0.98), as did those who were Asian American or Pacific Islander (aRR = 0.86; 95% CI, 0.76-0.98).<\/p>\n<p>\u201cThe barriers that get you from zero to any are maybe more fundamental, and the barriers that get you from some to all are maybe a little more, how much do you like your provider? How regularly do you go? What else are you dealing with health-wise that you have to work around? How much do you understand why you would get one screening or another?\u201d Spencer said. \u201cWhat we have to do to get the absolutely underscreened to screen for all of these things is a different process than what we have to do to identify women who are going into the doctor, getting some screenings, but they\u2019re just missing one.\u201d<\/p>\n<p>Based on the findings, researchers estimated 17.9 million women aged 45 to 64 years in the U.S. to be overdue for at least one screening.<\/p>\n<p>Of those, Spencer and colleagues projected most (10.3 million) to be overdue for one test, primarily colorectal cancer screening (6 million). They also estimated 4.4 million women were not up to date on two tests, and 3.2 million were overdue for all three screenings.<\/p>\n<p>Among 12.6 million not up to date on colorectal cancer screening, researchers projected 52.4% to be overdue for breast and\/or cervical cancer screening. Among 8.5 million women who had not gotten a <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20251215\/pcps-have-concerns-about-certain-riskbased-breast-cancer-screening-recommendations\" id=\"rId16\" target=\"_blank\">mammogram<\/a>, 72.9% also are likely due for cervical and\/or colorectal cancer screening. And among 7.2 million estimated to be overdue for <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260513\/overwhelming-support-for-hormone-therapy-in-cervical-cancer-but-barriers-limit-use\" id=\"rId17\" target=\"_blank\">cervical cancer<\/a> screening, 70.8% are projected to be due for mammogram or colorectal cancer screening.<\/p>\n<p>\u201cPeople need so much in terms of preventive health care,\u201d Spencer said. \u201cInstead of thinking about all of this in silos, we [must realize] a whole person might need multiple things.\u201d<\/p>\n<p>Researchers acknowledged study limitations, including use of self-reported data.<\/p>\n<p>Spencer noted future studies should investigate how to best reach people overdue for one screening or multiple tests.<\/p>\n<p>Challenges exist though, including guidelines recommending screenings at different frequencies.<\/p>\n<p>Mailed interventions, educational materials with details on all tests, as well as patient navigations are \u201cpromising\u201d avenues to explore, Spencer said.<\/p>\n<p>\u201cI\u2019m really interested in this population that\u2019s overdue for multiple things,\u201d Spencer said. \u201cI think that\u2019s where you get the most potential impact, understanding what works, and what impact we could potentially have through these interventions. Being able to demonstrate that we\u2019re getting meaningful health benefit from these interventions is also important. Are we really moving the needle on things we care about?\u201d<\/p>\n<h2>For more information:<\/h2>\n<p> <b>Jennifer C. Spencer, PhD,<\/b> can be reached at <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260624\/mailto:jennifer_spencer@austin.utexas.edu\" id=\"rId18\" target=\"_blank\">jennifer_spencer@austin.utexas.edu<\/a>.<\/p>\n<div class=\"article__content--footer\">\n<div class=\"publisher-logo\">\n<span>Published by:<\/span><br \/>\n<img decoding=\"async\" src=\"https:\/\/www.healio.com\/~\/media\/h5\/feature\/news\/publogos\/hot.svg?la=en&amp;h=24&amp;w=141&amp;hash=2F86D471C8514C0E334E329AA799E8B4\" class=\"logo-img\" height=\"24\" alt=\"hemonc today logo\" width=\"141\"\/>\n<\/div>\n<div class=\"healio-ai-component-inline\" data-no-ads=\"true\" data-module-track-category=\"Healio AI\" data-module-track-action=\"Click\" data-module-track-label=\"Access Healio Ai from component - News_AI Component - In-Content (all devices)\">\n<div class=\"healio-ai-content\">\n<img decoding=\"async\" src=\"https:\/\/m3.healio.com\/~\/media\/images\/healio-ai\/healio-ai_logo.svg\" alt=\"Healio AI\" class=\"healio-ai-logo\"\/><\/p>\n<p><strong>Ask a clinical question<\/strong> and tap into <strong>Healio AI&#8217;s knowledge<\/strong> base.<\/p>\n<ul>\n<li>PubMed, enrolling\/recruiting trials, guidelines<\/li>\n<li>Clinical Guidance, Healio CME, FDA news<\/li>\n<li>Healio&#8217;s exclusive daily news coverage of clinical data<\/li>\n<\/ul>\n<p><button class=\"healio-ai-button\" onclick=\"window.location.href=\" https:=\"\">Learn more<\/button>\n<\/div>\n<\/div>\n<div class=\"email-alert-button-wrapper d-none\" data-component=\"EmailTopicAlert\" data-module=\"Subspecialty Email Topic Alerts Top\" data-manage-email-link=\"\/footer\/account-information\/my-account\/email-subscriptions-and-alerts#emailAlerts\">\n<hidden data-setting-item=\"d265901d-6d37-49c7-a8f6-c7bf19a02509\"\/><br \/>\n<hidden data-crm-source=\"Subspecialty Topic Alert\"\/><\/p>\n<div class=\"email-alert-button d-none\" data-topic-button=\"not-subscribed\">\n<p>\n<span data-module-track-action=\"Email Alerts TOP_Click_Healio News Article\" data-module-track-label=\"Email Alerts TOP_Healio News Article\"><br \/>\n<i class=\"fas fa-plus-circle\"\/><br \/>\nAdd topic to email alerts<br \/>\n<\/span>\n<\/p>\n<div class=\"email-alert-inner collapse uef361e678cee455b9277cd626777d078\">\n<div class=\"email-alert-dialogue\">\n<p>\nReceive an email when new articles are posted on <span data-content=\"topic-title\"\/>\n<\/p>\n<div class=\"d-none\" data-sign-up-type=\"unknown\">\nPlease provide your email address to receive an email when new articles are posted on <span data-content=\"topic-title\"\/>.<\/p>\n<\/div>\n<\/div>\n<p><button type=\"button\" class=\"btn btn-primary\" data-loading-text=\"Loading &lt;i class=\" fa=\"\" fa-spinner=\"\" fa-spin=\"\">&#8221; data-action=subscribe&gt;<br \/>\nSubscribe<br \/>\n<\/button>\n<\/div>\n<\/div>\n<div class=\"d-none\" data-topic-modal=\"failed\"> <strong>We were unable to process your request. Please try again later. If you continue to have this issue please contact <a href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260624\/mailto:customerservice@slackinc.com\">customerservice@slackinc.com<\/a>.<\/strong> <\/p>\n<p><button data-dismiss=\"modal\" class=\"btn btn-primary btn-lg btn-block\">Back to Healio<\/button><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260624\/millions-of-women-overdue-for-at-least-one-routine-cancer-screening-test\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . &#8221; data-action=subscribe&gt; Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: Researchers estimate almost 18 million women aged 45 to 64 years are not up to date with breast, cervical or colorectal cancer screenings. More than 3 million women may be overdue for all those screenings. Nearly 18 million women in the U.S. aged 45 to 64 years are likely overdue for breast, cervical or colorectal cancer screenings, and more than 3 million are estimated to not be up to date on all three. Survey data from 68,000 women showed that having annual wellness visits and a regular health care provider significantly increased the likelihood of being up to date with at least one, as well as all screenings. Greater educational attainment and being insured also were associated with higher screening uptake. Data derived from Spencer JC, et al. JAMA Netw Open. 2026;doi:10.1001\/jamanetworkopen.2026.12976. However, interventions targeting multiple screenings could be beneficial, as only 50% of the cohort reported having all their tests completed. Jennifer C. Spencer \u201cWe tend to think about these [screenings] in silos,\u201d Jennifer C. Spencer, PhD, assistant professor in the departments of population health and internal medicine at The University of Texas at Austin Dell Medical School, told Healio. \u201cPeople tend to research one cancer screening or develop interventions to address colorectal cancer screening, or breast cancer screening, or cervical cancer screening. Those are really important, but we really have a chance to intervene holistically with those folks who are due for screenings, and identify everything that they\u2019re due for.\u201d \u2018Are there patterns?\u2019 Cancer is the leading cause of death among women aged 45 to 64 years in the U.S., according to study background. More than 70,000 women will die from breast, cervical or colorectal cancer alone this year, according to American Cancer Society\u2019s Cancer Statistics 2026 report. Prior research has shown that patients who screen for these malignancies are diagnosed at earlier stages and have improved cancer-specific mortality. However, many women are not up to date on screening. NCI estimates 20.2% of eligible patients have not had a mammogram in the past 2 years, and the numbers increase for those who are overdue for cervical (24.1%) and colorectal cancer (26.1%) screenings. \u201cWe see so many similar patterns in who doesn\u2019t get screened for breast cancer, for cervical cancer and for colorectal cancer,\u201d Spencer said. \u201cInsurance, access to care, having a regular care provider are commonly associated with lower screening rates.\u201d Yet, most investigations and interventions focus solely on screening for a single malignancy, even though there can be broad eligibility overlap, particularly for patients aged 45 to 64 years. \u201cWhat if we looked at all of this in one question?\u201d Spencer asked. \u201cWhat are the patterns within these three cancer screenings for the women who are due? Are there patterns that are very clear about who is due for just one, or all three, or none?\u201d Spencer and colleagues used data from the 2024 Behavioral Risk Factor Surveillance Survey, a nationally representative survey, to investigate. Their final sample included 68,111 women (mean age, 54.8 years; standard deviation, 5.8; 69.6% white), which represented a weighted U.S. population of 36.2 million. Up to date use of breast, cervical and colorectal cancer screenings served as the primary endpoint. \u2018Halfway there\u2019 Researchers found 50.3% of women to be up to date with all three screenings, 28.8% with two and 13.2% with one, while 7.7% were not up to date with any screenings. \u201cWe were surprised at the women who were up to date on some, but not all screenings,\u201d Spencer said. \u201cI expected it to be either you\u2019re pro-screening and you get everything, or you\u2019re less likely to screen and you get nothing.\u201d \u201cHalf of women being up to date on all three was lower than I expected, but my clinical colleagues were pleasantly surprised that half of women were up to date,\u201d she added. \u201cThey spend so much of their time trying to get people to use these cancer screenings, they were like, \u2018We\u2019re halfway there. That\u2019s pretty good.\u2019\u201d Factors that had a significant association with being up to date for at least one screening compared with none included having a checkup in the previous year (adjusted RR = 1.22; 95% CI, 1.19-1.25), having a regular health care practitioner (aRR = 1.18; 95% CI, 1.13-1.23), being Black (aRR = 1.02; 95% CI, 1.01-1.04) or Hispanic (aRR = 1.06; 95% CI, 1.05-1.08) vs. white, having a high school degree or greater educational attainment, having insurance, being older, and being able to afford care in the previous year. Most of those factors also had a significant association with being up to date with all screenings vs. any screening, but with greater magnitudes. Women up to date with all their screenings had a higher likelihood of having a wellness visit in the past year (aRR = 1.71; 95% CI, 1.57-1.86), a regular health care practitioner (aRR = 1.43; 95% CI, 1.24-1.66), private insurance compared with no insurance (aRR = 1.43; 95% CI, 1.24-1.63), a college degree vs. not finishing high school (aRR = 1.28; 95% CI, 1.16-1.41), and older age (age 60-64 years vs. 45-50; aRR = 1.57; 95% CI, 1.49-1.66). \u201cGetting people in the door is huge, but for people who have some but not all screenings, 80% of that group did have a wellness visit in the past year,\u201d Spencer said. \u201cWe see that there\u2019s room for improvement.\u201d Women living in rural areas had significantly lower odds of having all screenings completed (aRR = 0.94; 95% CI, 0.89-0.98), as did those who were Asian American or Pacific Islander (aRR = 0.86; 95% CI, 0.76-0.98). \u201cThe barriers that get you from zero to any are maybe more fundamental, and the barriers that<\/p>\n","protected":false},"author":1,"featured_media":2945,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2944","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts\/2944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2944"}],"version-history":[{"count":0,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts\/2944\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/media\/2945"}],"wp:attachment":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}